In situ label-free quantification of human pluripotent stem cells with electrochemical potential.

Conventional methods for quantification of undifferentiated pluripotent stem cells such as fluorescence-activated cell sorting and real-time PCR analysis have technical limitations in terms of their sensitivity and recyclability. Herein, we designed a real-time in situ label-free monitoring system on the basis of a specific electrochemical signature of human pluripotent stem cells in vitro. The intensity of the signal of hPSCs highly corresponded to the cell number and remained consistent in a mixed population with differentiated cells. The electrical charge used for monitoring did not markedly affect the proliferation rate or molecular characteristics of differentiated human aortic smooth muscle cells. After YM155 treatment to ablate undifferentiated hPSCs, their specific signal was significantly reduced. This suggests that detection of the specific electrochemical signature of hPSCs would be a valid approach to monitor potential contamination of undifferentiated hPSCs, which can assess the risk of teratoma formation efficiently and economically.

[1]  Jeong-Woo Choi,et al.  In situ electrochemical detection of embryonic stem cell differentiation. , 2013, Journal of biotechnology.

[2]  S. Mitalipov,et al.  Human Embryonic Stem Cells Derived by Somatic Cell Nuclear Transfer , 2013, Cell.

[3]  Pierre O. Bagnaninchi,et al.  Real-time label-free monitoring of adipose-derived stem cell differentiation with electric cell-substrate impedance sensing , 2011, Proceedings of the National Academy of Sciences.

[4]  Kwang-Hoon Chun,et al.  Timely Degradation of Wip1 Phosphatase by APC/C Activator Protein Cdh1 is Necessary for Normal Mitotic Progression , 2015, Journal of cellular biochemistry.

[5]  N. Benvenisty,et al.  Immunologic and chemical targeting of the tight-junction protein Claudin-6 eliminates tumorigenic human pluripotent stem cells , 2013, Nature Communications.

[6]  Miranda Yap,et al.  Selection Against Undifferentiated Human Embryonic Stem Cells by a Cytotoxic Antibody Recognizing Podocalyxin‐Like Protein‐1 , 2008, Stem cells.

[7]  Jeong-Woo Choi,et al.  Cell-based chip for the detection of anticancer effect on HeLa cells using cyclic voltammetry. , 2009, Biosensors & bioelectronics.

[8]  Tae-Hee Lee,et al.  Functional Recapitulation of Smooth Muscle Cells Via Induced Pluripotent Stem Cells From Human Aortic Smooth Muscle Cells , 2010, Circulation research.

[9]  C. Ryu,et al.  Development of a decoy immunization strategy to identify cell-surface molecules expressed on undifferentiated human embryonic stem cells , 2008, Cell and Tissue Research.

[10]  Yang Xu,et al.  A Scalable Approach to Prevent Teratoma Formation of Human Embryonic Stem Cells* , 2012, The Journal of Biological Chemistry.

[11]  John B. Shoven,et al.  I , Edinburgh Medical and Surgical Journal.

[12]  Jeong-Woo Choi,et al.  Effects of nanopatterned RGD peptide layer on electrochemical detection of neural cell chip. , 2010, Biosensors & bioelectronics.

[13]  T. Alford,et al.  A Low-Cost Electrochemical Biosensor for Rapid Bacterial Detection , 2011, IEEE Sensors Journal.

[14]  Yu Sun,et al.  Classification of cell types using a microfluidic device for mechanical and electrical measurement on single cells. , 2011, Lab on a chip.

[15]  D. Sahoo,et al.  An antibody against SSEA-5 glycan on human pluripotent stem cells enables removal of teratoma-forming cells , 2011, Nature Biotechnology.

[16]  S. Moon,et al.  A porous membrane-mediated isolation of mesenchymal stem cells from human embryonic stem cells. , 2015, Tissue engineering. Part C, Methods.

[17]  Jeong-Woo Choi,et al.  Multilevel Biomemory Device Consisting of Recombinant Azurin/Cytochrome c , 2010, Advanced materials.

[18]  Hefeng Huang,et al.  Oxidative stress induces H2AX phosphorylation in human spermatozoa , 2006, FEBS letters.

[19]  Jae Min Lim,et al.  Improvement of Postnatal Neovascularization by Human Embryonic Stem Cell–Derived Endothelial-Like Cell Transplantation in a Mouse Model of Hindlimb Ischemia , 2007, Circulation.

[20]  S. Nishikawa,et al.  Highly Sensitive In Vitro Methods for Detection of Residual Undifferentiated Cells in Retinal Pigment Epithelial Cells Derived from Human iPS Cells , 2012, PloS one.

[21]  S. Moon,et al.  Inhibition of pluripotent stem cell-derived teratoma formation by small molecules , 2013, Proceedings of the National Academy of Sciences.

[22]  A. Fornace,et al.  Wip1 directly dephosphorylates gamma-H2AX and attenuates the DNA damage response. , 2010, Cancer research.

[23]  M. Schuldiner,et al.  Selective Ablation of Human Embryonic Stem Cells Expressing a “Suicide” Gene , 2003, Stem cells.

[24]  Jens Kurth,et al.  Assessing the safety of stem cell therapeutics. , 2011, Cell stem cell.

[25]  S. El‐Safty,et al.  Fabrication of a highly selective nonenzymatic amperometric sensor for hydrogen peroxide based on nickel foam/cytochrome c modified electrode , 2015 .

[26]  I. Giaever,et al.  Monitoring fibroblast behavior in tissue culture with an applied electric field. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[27]  M. Yap,et al.  mAb 84, a Cytotoxic Antibody that Kills Undifferentiated Human Embryonic Stem Cells via Oncosis , 2009, Stem cells.

[28]  L. Looijenga,et al.  Lessons from human teratomas to guide development of safe stem cell therapies , 2012, Nature Biotechnology.

[29]  A. Connolly,et al.  Effects of cell number on teratoma formation by human embryonic stem cells , 2009, Cell cycle.

[30]  R. Stewart,et al.  Human Induced Pluripotent Stem Cells Free of Vector and Transgene Sequences , 2009, Science.

[31]  I. Weissman,et al.  Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies , 2013, Nature Medicine.

[32]  P. Zandstra,et al.  Culture development for human embryonic stem cell propagation: molecular aspects and challenges. , 2005, Current opinion in biotechnology.

[33]  Mitchell D. Probasco,et al.  Feeder-independent culture of human embryonic stem cells , 2006, Nature Methods.

[34]  Shinya Yamanaka,et al.  A chemical probe that labels human pluripotent stem cells. , 2014, Cell reports.

[35]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[36]  J. Hirabayashi,et al.  A medium hyperglycosylated podocalyxin enables noninvasive and quantitative detection of tumorigenic human pluripotent stem cells , 2014, Scientific Reports.

[37]  Yinan Qin,et al.  Highly sensitive and selective detection of cancer cell with a label-free electrochemical cytosensor. , 2013, Biosensors & bioelectronics.

[38]  J. Durrant,et al.  Cyclic voltammetry and voltabsorptometry studies of redox proteins immobilised on nanocrystalline tin dioxide electrodes. , 2004, Bioelectrochemistry.

[39]  Tae-Hyung Kim,et al.  Fabrication of new single cell chip to monitor intracellular and extracellular redox state based on spectroelectrochemical method. , 2015, Biomaterials.

[40]  Jun Li,et al.  A fluorescent rosamine compound selectively stains pluripotent stem cells. , 2010, Angewandte Chemie.

[41]  W. Dai,et al.  Osmotic Stress-induced Phosphorylation of H2AX by Polo-like Kinase 3 Affects Cell Cycle Progression in Human Corneal Epithelial Cells* , 2014, The Journal of Biological Chemistry.

[42]  N. Benvenisty,et al.  Chemical ablation of tumor-initiating human pluripotent stem cells , 2014, Nature Protocols.

[43]  J. Thomson,et al.  Embryonic stem cell lines derived from human blastocysts. , 1998, Science.

[44]  P. Rosenfeld,et al.  Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies , 2015, The Lancet.

[45]  Y. Hoki,et al.  Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells , 2013, Nature.